Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns

Clin Infect Dis. 1997 Jul;25(1):163-4. doi: 10.1086/516895.

Authors

W B Furlong¹, T A Rakowski

Affiliation

¹ Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.

PMID: 9243059
DOI: 10.1086/516895

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use*
Drug Resistance, Microbial
Endocarditis, Bacterial / drug therapy*
Endocarditis, Bacterial / microbiology
Enterococcus faecium / drug effects*
Enterococcus faecium / isolation & purification
Female
Gram-Positive Bacterial Infections / drug therapy*
Gram-Positive Bacterial Infections / microbiology
Humans
Middle Aged
Prosthesis-Related Infections / drug therapy*
Prosthesis-Related Infections / microbiology
Vancomycin / pharmacology
Virginiamycin / therapeutic use*

Substances

Anti-Bacterial Agents
Virginiamycin
quinupristin-dalfopristin
Vancomycin